Latest Hydromorphone Stories
BETHESDA, Md., May 26 /PRNewswire/ -- On May 27 and 28, 2009, the Food and Drug Administration (FDA) will hear testimony about the FDA-guided effort to develop a classwide Risk Evaluation and Mitigation Strategy (REMS) for all controlled-release opioids from more than 70 patients, scientists, public health professionals, and representatives of pharmacist groups, prescriber groups, and pharmaceutical companies.
Oh Thursday, the Food and Drug Administration reversed its initial plan to remove unapproved liquid morphine from being sold in the US.
The Food and Drug Administration told nine manufacturers to quit distributing 14 unapproved narcotic painkillers drugs within 90 days.
CONSHOHOCKEN, PA and VANCOUVER, BC, March 23 /PRNewswire/ - Neuromed Pharmaceuticals, Inc.
ST. LOUIS, Jan.
ST. LOUIS, Dec.
Covidien, a provider of healthcare products, has announced the US availability of TussiCaps extended-release capsules, the first and only hydrocodone antitussive oral capsule to provide powerful cough suppression for up to 12 hours.
Vyteris has announced an initiative to identify and target candidate drugs in the pain management field that could potentially be delivered using the company's active patch transdermal system.
By Suzanne Ulbrich, The Daily News, Jacksonville, N.C. Jul. 16--The State Bureau of Investigation has charged a licensed practical nurse of stealing drugs from Onslow Memorial Hospital while employed there.